RxDoctor Payments Data

Cory Hall

Nurse Practitioner · Pomona, NJNPI 1184488835

Payments from drug & device makers

$834in general payments, 2019–2025

Across 40 payments — averaging $20.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$479
  • Scpharmaceuticals Inc.$184
  • Pfizer$64
  • E.r. Squibb & Sons, L.L.C.$43
  • Bridgebio Pharma, Inc.$17
  • Johnson & Johnson$16
  • plus $31 from 2 others

What the payments were for

  • Food & beverage$834100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$834 in reported general payments places this provider in the 75th percentile of 2,138 nurse practitioner providers in New Jersey.

See all nurse practitioner providers in New Jersey

Medicare billing

Part B allowed, 2024
$9,768
Medicare patients
101
Services billed
140

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban55$73,081
Atorvastatin Calcium112$1,301
Metoprolol Succinate66$883
Rosuvastatin Calcium40$660
Ezetimibe32$536
Valsartan16$507
Losartan Potassium38$452
ClopidogrelClopidogrel Bisulfate20$359
Carvedilol38$342
Hydralazine Hcl16$330
Amlodipine Besylate34$328
Furosemide46$258
Isosorbide Mononitrate ErIsosorbide Mononitrate12$218
Metoprolol Tartrate34$189
Atenolol19$163

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$64$73,08155 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,138 nurse practitioner providers in New Jersey.

Other nurse practitioner in Pomona

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →